@article{TAU20831,
author = {Venkat M. Ramakrishnan and Jairam R. Eswara},
title = {The timing of radical cystectomy following neoadjuvant chemotherapy},
journal = {Translational Andrology and Urology},
volume = {7},
number = {Suppl 6},
year = {2018},
keywords = {},
abstract = {Low-morbidity therapies such as intravesical chemo- and immunotherapies and transurethral resection of bladder tumor (TURBT) are effective options for patients with localized, non-invasive bladder cancer. However, muscle-invasive bladder cancer (MIBC) typically requires more definitive management that is often associated with a higher morbidity and a higher rate of perioperative complications, and radical cystectomy (RC) is regarded as the standard of care for patients with advanced disease (1).},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/20831}
}